Planet 13 Holdings (PLNH) EBITDA Margin (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly EBITDA Margin came in at 19.95% in Q1 2026, down 261.0% year-on-year from 12.39% in Q1 2025, and down 9.29% on a QoQ basis from 18.25% in Q4 2025.
Planet 13 Holdings (PLNH) EBITDA Margin (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of EBITDA Margin data on file, last reported at 19.95% in Q1 2026.
- On a quarterly basis, EBITDA Margin fell 261.0% year-over-year to 19.95% in Q1 2026; TTM through Mar 2026 was 55.16%, a 2866.0% decrease from a year earlier, with the FY2025 full-year figure at 57.35%, down 2684.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 19.95%, down from 18.25% in the prior quarter.
- Over the last five years, EBITDA Margin for PLNH reached as high as 0.52% in Q2 2022 and fell as low as 169.57% in Q3 2023.
- Historically, EBITDA Margin has averaged 43.31% across 5 years, with a median of 17.34% in 2025.
- Across the five-year window, EBITDA Margin soared 63115 bps in 2022 and tumbled 16626 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 156.33% in 2022, then surged by 74 bps to 39.92% in 2023, then tumbled by 107 bps to 82.5% in 2024, then surged by 78 bps to 18.25% in 2025, then declined by 9 bps to 19.95% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 19.95% in Q1 2026, 18.25% in Q4 2025, and 169.27% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -19.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.95% |
| Dec 31, 2025 | -18.25% |
| Sep 30, 2025 | -169.27% |
| Jun 30, 2025 | -18.58% |
| Mar 31, 2025 | -17.34% |
| Dec 31, 2024 | -82.50% |
| Sep 30, 2024 | -3.01% |
| Jun 30, 2024 | -4.49% |
| Mar 31, 2024 | -7.02% |
| Dec 31, 2023 | -39.92% |
| Sep 30, 2023 | -169.57% |
| Jun 30, 2023 | -5.87% |
| Mar 31, 2023 | -8.80% |
| Dec 31, 2022 | -156.33% |
| Sep 30, 2022 | -9.42% |
| Jun 30, 2022 | 0.52% |
| Mar 31, 2022 | -6.50% |
| Dec 31, 2021 | 8.32% |
| Sep 30, 2021 | -21.03% |
| Jun 30, 2021 | -630.64% |